296
82. Miller W, Sharpe R. Environmental oestrogens and human reproductive cancers. Endocr
Relat Cancer. 1998;5(2):69–96.
83. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, et al.
Male reproductive health and environmental xenoestrogens. Environ Health Perspect. 1996;
104(suppl 4):741–803.
84. Maffini MV, Rubin BS, Sonnenschein C, Soto AM. Endocrine disruptors and reproductive
health: the case of bisphenol-A. Mol Cell Endocrinol. 2006;254:179–86.
85. Skakkebæk N-E, Meyts R-D, Main K. Testicular dysgenesis syndrome: an increasingly
common developmental disorder with environmental aspects: opinion. Hum Reprod. 2001;
16(5):972–8.
86. Staessen JA, Nawrot T, Den Hond E, Thijs L, Fagard R, Hoppenbrouwers K, et al. Renal
function, cytogenetic measurements, and sexual development in adolescents in relation to
environmental pollutants: a feasibility study of biomarkers. Lancet. 2001;357(9269):1660–9.
87. Biles J, McNeal T, Begley T, Hollifield H. Determination of bisphenol-A in reusable polycarbonate food-contact plastics and migration to food-simulating liquids. J Agric Food Chem.
1997;45(9):3541–4.
88. Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod.
2002;17(11):2839–41.
89. Sugiura-Ogasawara M, Ozaki Y, Sonta S-i, Makino T, Suzumori K. Exposure to bisphenol A
is associated with recurrent miscarriage. Hum Reprod. 2005;20(8):2325–9.
90. Mauvais-Jarvis F. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex
Differ. 2015;6(1):14.
91. Rubin BS, Soto AM. Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol.
2009;304(1–2):55–62.
92. Patisaul HB, Polston EK. Influence of endocrine active compounds on the developing rodent
brain. Brain Res Rev. 2008;57(2):352–62.
93. Martini M, Miceli D, Gotti S, Viglietti-Panzica C, Fissore E, Palanza P, et al. Effects of perinatal administration of bisphenol A on the neuronal nitric oxide synthase expressing system in
the hypothalamus and limbic system of CD1 mice. J Neuroendocrinol. 2010;22(9):1004–12.
94. Hoppe AA, Carey GB. Polybrominated diphenyl ethers as endocrine disruptors of adipocyte
metabolism. Obesity. 2007;15(12):2942–50.
95. Hao C-j, Cheng X-j, Xia H-f, Ma X. The endocrine disruptor 4-nonylphenol promotes adipocyte differentiation and induces obesity in mice. Cell Physiol Biochem. 2012;30(2):382–94.
96. Abdollahi M, Donyavi M, Pournourmohammadi S, Saadat M. Hyperglycemia associated
with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in
rats following subchronic exposure to malathion. Comp Biochem Physiol Part C Toxicol
Pharmacol. 2004;137(4):343–7.
97. Ma Y, Xia W, Wang D, Wan Y, Xu B, Chen X, et al. Hepatic DNA methylation modifications
in early development of rats resulting from perinatal BPA exposure contribute to insulin
resistance in adulthood. Diabetologia. 2013;56(9):2059–67.
98. Perreault L, McCurdy C, Kerege AA, Houck J, Færch K, Bergman BC. Bisphenol A impairs
hepatic glucose sensing in C57BL/6 male mice. PLoS One. 2013;8(7):e69991.
99. Skinner MK. Endocrine disruptor induction of epigenetic transgenerational inheritance of
disease. Mol Cell Endocrinol. 2014;398(1–2):4–12.
100. Rissman EF, Adli M. Minireview: transgenerational epigenetic inheritance: focus on endocrine disrupting compounds. Endocrinology. 2014;155(8):2770–80.
101. Sales LB, Kamstra J, Cenijn P, Van Rijt L, Hamers T, Legler J. Effects of endocrine disrupting
chemicals on in vitro global DNA methylation and adipocyte differentiation. Toxicol in Vitro.
2013;27(6):1634–43.
102. Kamstra JH, Hruba E, Blumberg B, Janesick A, Mandrup S, Hamers T, et al. Transcriptional
and epigenetic mechanisms underlying enhanced in vitro adipocyte differentiation by the
brominated flame retardant BDE-47. Environ Sci Technol. 2014;48(7):4110–9.
S. Kamal et al.
82. Miller W, Sharpe R. Environmental oestrogens and human reproductive cancers. Endocr
Relat Cancer. 1998;5(2):69–96.
83. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, et al.
Male reproductive health and environmental xenoestrogens. Environ Health Perspect. 1996;
104(suppl 4):741–803.
84. Maffini MV, Rubin BS, Sonnenschein C, Soto AM. Endocrine disruptors and reproductive
health: the case of bisphenol-A. Mol Cell Endocrinol. 2006;254:179–86.
85. Skakkebæk N-E, Meyts R-D, Main K. Testicular dysgenesis syndrome: an increasingly
common developmental disorder with environmental aspects: opinion. Hum Reprod. 2001;
16(5):972–8.
86. Staessen JA, Nawrot T, Den Hond E, Thijs L, Fagard R, Hoppenbrouwers K, et al. Renal
function, cytogenetic measurements, and sexual development in adolescents in relation to
environmental pollutants: a feasibility study of biomarkers. Lancet. 2001;357(9269):1660–9.
87. Biles J, McNeal T, Begley T, Hollifield H. Determination of bisphenol-A in reusable polycarbonate food-contact plastics and migration to food-simulating liquids. J Agric Food Chem.
1997;45(9):3541–4.
88. Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod.
2002;17(11):2839–41.
89. Sugiura-Ogasawara M, Ozaki Y, Sonta S-i, Makino T, Suzumori K. Exposure to bisphenol A
is associated with recurrent miscarriage. Hum Reprod. 2005;20(8):2325–9.
90. Mauvais-Jarvis F. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex
Differ. 2015;6(1):14.
91. Rubin BS, Soto AM. Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol.
2009;304(1–2):55–62.
92. Patisaul HB, Polston EK. Influence of endocrine active compounds on the developing rodent
brain. Brain Res Rev. 2008;57(2):352–62.
93. Martini M, Miceli D, Gotti S, Viglietti-Panzica C, Fissore E, Palanza P, et al. Effects of perinatal administration of bisphenol A on the neuronal nitric oxide synthase expressing system in
the hypothalamus and limbic system of CD1 mice. J Neuroendocrinol. 2010;22(9):1004–12.
94. Hoppe AA, Carey GB. Polybrominated diphenyl ethers as endocrine disruptors of adipocyte
metabolism. Obesity. 2007;15(12):2942–50.
95. Hao C-j, Cheng X-j, Xia H-f, Ma X. The endocrine disruptor 4-nonylphenol promotes adipocyte differentiation and induces obesity in mice. Cell Physiol Biochem. 2012;30(2):382–94.
96. Abdollahi M, Donyavi M, Pournourmohammadi S, Saadat M. Hyperglycemia associated
with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase in
rats following subchronic exposure to malathion. Comp Biochem Physiol Part C Toxicol
Pharmacol. 2004;137(4):343–7.
97. Ma Y, Xia W, Wang D, Wan Y, Xu B, Chen X, et al. Hepatic DNA methylation modifications
in early development of rats resulting from perinatal BPA exposure contribute to insulin
resistance in adulthood. Diabetologia. 2013;56(9):2059–67.
98. Perreault L, McCurdy C, Kerege AA, Houck J, Færch K, Bergman BC. Bisphenol A impairs
hepatic glucose sensing in C57BL/6 male mice. PLoS One. 2013;8(7):e69991.
99. Skinner MK. Endocrine disruptor induction of epigenetic transgenerational inheritance of
disease. Mol Cell Endocrinol. 2014;398(1–2):4–12.
100. Rissman EF, Adli M. Minireview: transgenerational epigenetic inheritance: focus on endocrine disrupting compounds. Endocrinology. 2014;155(8):2770–80.
101. Sales LB, Kamstra J, Cenijn P, Van Rijt L, Hamers T, Legler J. Effects of endocrine disrupting
chemicals on in vitro global DNA methylation and adipocyte differentiation. Toxicol in Vitro.
2013;27(6):1634–43.
102. Kamstra JH, Hruba E, Blumberg B, Janesick A, Mandrup S, Hamers T, et al. Transcriptional
and epigenetic mechanisms underlying enhanced in vitro adipocyte differentiation by the
brominated flame retardant BDE-47. Environ Sci Technol. 2014;48(7):4110–9.
S. Kamal et al.